Table 3. Multiple comparisons between diabetic patients without complications and diabetic patients with micro and macro-complications.
| T2DM- without complication | T2DM+* with micro complications | T2DM+** with macro complications | T2DM+* vs T2DM+** | |
|---|---|---|---|---|
| Mean(SD) | Mean(SD) | Mean(SD) | ||
| P value | P value | P value | P value | |
| Males | N = 113 | N = 101 | N = 88 | |
| Peaks (structure) | ||||
| P1 (NGA2F) | 9.63 (3.39) | 9.89 (3.38) | 9.54 (2.84) | |
| ns | ||||
| P2 (NGA2FB) | 1.78 (0.58) | 1.84 (0.88) | 1.9 (0.55) | |
| ns | ||||
| P3 (NG1(6)A2F) | 5.34 (1.39) | 5.28 (1.37) | 4.86 (1.29) | |
| P = 0.01 | ns | |||
| P4 (NG1(3)A2F) | 4.88 (0.91) | 4.87 (1.2) | 4.67 (0.9) | |
| ns | ||||
| P5 (NA2) | 43.97 (4.97) | 44.28 (5.02) | 44.58 (4.53) | |
| ns | ||||
| P6 (NA2F) | 17.49 (2.41) | 17.38 (2.83) | 17.47 (2.3) | |
| ns | ||||
| P7 (NA2FB) | 6.03 (1.65) | 5.97 (1.8) | 6.65 (2.5) | |
| ns | ||||
| P8 (NA3) | 6.68 (1.74) | 6.29 (1.69) | 6.13 (1.77) | |
| ns | ||||
| P9 (NA3F) | 2.83 (1.02) | 2.85 (1.14) | 2.91 (0.97) | |
| ns | ||||
| P10 (NA4) | 1.37 (0.45) | 1.33 (0.4) | 1.29 (0.43) | |
| ns |
For each peak the mean and the SD are indicated. The reference group in each comparison is T2DM-. For each comparison the nominal p-value is reported if < = 0.05.